Bench to Market: An Integrated Supply Chain Approach to Your Active Pharmaceutical Ingredients (API) from Europe

Globally, the contract development and manufacturing organization (CDMO) market is experiencing transformational forces influencing its growth. The COVID-19 pandemic has given the much-needed impetus to digital transformation in the pharmaceutical industry. Digitization initiatives include predictive analytics, real-time data tracking, remote working, and end-to-end digital connectivity in supply chains to improve efficiency by increasing productivity and reducing downtime and costs. Organizations that adapt, or work with the right partners to navigate these changes, will continue to lead the market.

Download this complimentary white paper to discover:

The Future for Contract Development and Manufacturing Organizations
The Evolution of Products and the Development Cycle
How to Simplify Drug Development and Manufacturing
The Benefits of an Integrated and Agile Approach
The Uquifa Model—From Development to Manufacture

Download the Complimentary White Paper

"*" indicates required fields

Name*

Job Title*

Company*

Phone*

Business Email*

Country*

Company Revenue*

This white paper is co-hosted in partnership with Frost & Sullivan and Uquifa. As a result, both Uquifa and Frost & Sullivan are collecting your personal data when you submit such information as part of the registration process above. For more information on each party’s privacy practices, please see: Uquifa Privacy Statement | Frost & Sullivan Privacy Notice.

Uquifa may use your personal data to inform you about its products, services and events.

Frost & Sullivan can notify me about products, services, and events.

Uquifa can notify me about products, services, and events.

CAPTCHA